Russia, Hualan Biological Bacterin agree on production of Sputnik V in China

Russia, Hualan Biological Bacterin agree on production of Sputnik V in China
Representative Image Image Credit: ANI
  • Country:
  • Russian Federation

Russia's RDIF sovereign wealth fund said on Monday it had agreed with Hualan Biological Bacterin to produce more than 100 million doses of the Sputnik V vaccine against COVID-19 in China.

RDIF said the two sides were committed to a long-term partnership in vaccine production.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.